|
JPH1050306A
(ja)
*
|
1996-07-31 |
1998-02-20 |
Toyota Autom Loom Works Ltd |
水素吸蔵合金電極の製造方法
|
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
|
US20050085498A1
(en)
*
|
1998-05-28 |
2005-04-21 |
Byrd Edward A. |
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
|
|
AU6283299A
(en)
*
|
1998-10-01 |
2000-04-17 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
JP2001107258A
(ja)
*
|
1999-10-06 |
2001-04-17 |
Hitachi Ltd |
無電解銅めっき方法とめっき装置および多層配線基板
|
|
ATE526950T1
(de)
|
1999-10-29 |
2011-10-15 |
Euro Celtique Sa |
Hydrocodon-formulierungen mit gesteuerter freisetzung
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
EP1118321A1
(fr)
*
|
2000-01-14 |
2001-07-25 |
Ucb, S.A. |
Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
|
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
|
GB0009522D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Smithkline Beecham Plc |
Composition
|
|
EP2283829A1
(en)
*
|
2000-10-30 |
2011-02-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US20060127474A1
(en)
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
|
SI1404304T1
(sl)
*
|
2001-06-28 |
2009-10-31 |
Ucb Farchim Sa Z I Planchy |
Tableta, obsegajoča cetirizin in psevdoefedrin
|
|
IL159287A0
(en)
*
|
2001-06-28 |
2004-06-01 |
Ucb Farchim Sa |
Tablet comprising cetirizine and pseudoephedrine
|
|
US20030092724A1
(en)
*
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
AU2003202550A1
(en)
*
|
2002-01-09 |
2003-07-24 |
Ucb, S.A. |
Pharmaceutical formulations with modified release
|
|
CA2481025A1
(en)
*
|
2002-04-04 |
2003-10-16 |
Tanya Havlir |
Palatable chewable tablet
|
|
EP1545468A4
(en)
*
|
2002-09-20 |
2007-06-20 |
Alpharma Inc |
SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
|
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
|
CA2507042A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ucb Farchim, S.A. |
Tablet comprising efletirizine and pseudoephedrine
|
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20050281875A1
(en)
*
|
2003-12-17 |
2005-12-22 |
Sovereign Pharmaceuticals, Ltd. |
Promethazine containing dosage form
|
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US9492541B2
(en)
*
|
2004-09-14 |
2016-11-15 |
Sovereign Pharmaceuticals, Llc |
Phenylepherine containing dosage form
|
|
US20050232986A1
(en)
*
|
2003-12-17 |
2005-10-20 |
David Brown |
Dosage form containing promethazine and another drug
|
|
US20050232987A1
(en)
*
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
|
US20060029664A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing carbetapentane and another drug
|
|
US7897172B2
(en)
*
|
2004-05-18 |
2011-03-01 |
L. Perrigo Company |
Tablets exhibiting reduced drug release variability
|
|
US9308164B2
(en)
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
|
US9592197B2
(en)
*
|
2004-12-16 |
2017-03-14 |
Sovereign Pharmaceuticals, Llc |
Dosage form containing diphenhydramine and another drug
|
|
US20070003622A1
(en)
*
|
2004-12-16 |
2007-01-04 |
Sovereign Pharmaceuticals, Ltd. |
Diphenhydramine containing dosage form
|
|
WO2006022996A2
(en)
*
|
2004-08-04 |
2006-03-02 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US7529255B2
(en)
*
|
2005-04-21 |
2009-05-05 |
Microsoft Corporation |
Peer-to-peer multicasting using multiple transport protocols
|
|
HRP20141185T1
(hr)
*
|
2005-07-26 |
2015-01-30 |
Ucb Pharma Sa |
Farmaceutski pripravci koji sadrže levetiracetam i proces za njihovu pripremu
|
|
EA014739B1
(ru)
*
|
2005-09-09 |
2011-02-28 |
Лабофарм Инк. |
Композиция тразодона для введения один раз в день
|
|
RU2008113439A
(ru)
|
2005-09-09 |
2009-10-20 |
Лабофарм Инк. (CA) |
Композиции с замедленным высвобождением лекарственного средства
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
SG169334A1
(en)
*
|
2006-01-21 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Dosage form and method for the delivery of drugs of abuse
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
KR100753480B1
(ko)
*
|
2006-01-27 |
2007-08-31 |
씨제이 주식회사 |
잘토프로펜 함유 서방성 정제 및 그 제조방법
|
|
US20070253927A1
(en)
*
|
2006-04-13 |
2007-11-01 |
Gwenaelle Jegou |
Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
|
|
US20100172984A1
(en)
*
|
2006-06-06 |
2010-07-08 |
Bijay Kumar Padhi |
tablet dosage form comprising cetirizine and pseudoephedrine
|
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
MX2008016349A
(es)
*
|
2006-06-19 |
2009-01-28 |
Accu Break Technologies Inc |
Formas segmentadas de dosificacion farmaceutica.
|
|
US8765178B2
(en)
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
EP2068713B1
(en)
|
2006-09-25 |
2012-07-18 |
Koninklijke Philips Electronics N.V. |
Shifting an object for complete trajectories in rotational x-ray imaging
|
|
JP2010522135A
(ja)
|
2006-10-09 |
2010-07-01 |
チャールストン ラボラトリーズ，インコーポレイテッド |
医薬組成物
|
|
WO2008064192A2
(en)
|
2006-11-21 |
2008-05-29 |
Mcneil-Ppc, Inc. |
Modified release analgesic suspensions
|
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
|
JP5453280B2
(ja)
*
|
2007-10-16 |
2014-03-26 |
ラボファーム インコーポレイテッド |
アセトアミノフェンおよびトラマドールを持続的に放出するための二層組成物
|
|
WO2009067605A2
(en)
*
|
2007-11-21 |
2009-05-28 |
The Procter & Gamble Company |
Preparations, methods and kits useful for treatment of cough
|
|
WO2009076764A1
(en)
*
|
2007-12-17 |
2009-06-25 |
Labopharm Inc. |
Misuse preventative, controlled release formulation
|
|
JP5714910B2
(ja)
|
2008-01-09 |
2015-05-07 |
チャールストン ラボラトリーズ，インコーポレイテッド |
薬学的組成物
|
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
|
CN102316857A
(zh)
|
2008-12-16 |
2012-01-11 |
莱博法姆公司 |
防止误用的控释配方
|
|
EP2381937A2
(en)
|
2008-12-31 |
2011-11-02 |
Upsher-Smith Laboratories, Inc. |
Opioid-containing oral pharmaceutical compositions and methods
|
|
EP3311667A1
(en)
|
2009-07-08 |
2018-04-25 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
EP2477610A1
(en)
|
2009-09-17 |
2012-07-25 |
Upsher-Smith Laboratories, Inc. |
A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti -inflammatory drug
|
|
CA2798702A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholresistant metoprolol-containing extended-release oral dosage forms
|
|
CN102302497A
(zh)
*
|
2011-05-18 |
2012-01-04 |
天圣制药集团股份有限公司 |
一种治疗过敏性鼻炎的制剂及其制备方法
|
|
ES2795291T3
(es)
|
2013-02-13 |
2020-11-23 |
Procter & Gamble |
Medicamento con sabor a anís
|
|
KR102070076B1
(ko)
*
|
2013-05-03 |
2020-01-29 |
주식회사 제닉 |
탄산 함유 입자를 포함하는 필름
|
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
|
BR112016020877B1
(pt)
|
2014-03-11 |
2022-11-29 |
Redhill Biopharma Ltd |
Uso de ondansetron, uso de um núcleo compreendendo uma matriz polímera não iônica e comprimido
|
|
JP2019507181A
(ja)
|
2016-03-04 |
2019-03-14 |
チャールストン ラボラトリーズ，インコーポレイテッド |
医薬組成物
|
|
RU2687715C1
(ru)
*
|
2018-05-07 |
2019-05-15 |
Федеральное государственное бюджетное учреждение науки Институт горного дела Дальневосточного отделения Российской академии наук |
Способ комбинированной разработки россыпных месторождений золота
|
|
US12589083B2
(en)
|
2019-05-07 |
2026-03-31 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
EP3965733A4
(en)
|
2019-05-07 |
2023-01-11 |
Clexio Biosciences Ltd. |
ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE
|
|
KR102073185B1
(ko)
*
|
2019-07-16 |
2020-02-04 |
(주)위바이오트리 |
활성성분을 포함하는 변성 다중층 수산화물 구조체를 포함하는 금속 수산화물 복합체 및 이의 제조 방법
|